Moreover, IFN-γ mediates the cellular process in immune responses of humoral adaptivity, whereas IFN-λ1 treatment inhibits the autophagic activity in human hepatoma cells (18, 55). Here, IFNL1 is linked to hepatocellular carcinoma.